Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Altimmune Inc (NQ: ALT )

2.600 +0.100 (+4.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 984,938
Open 2.500
Bid (Size) 2.580 (10)
Ask (Size) 2.600 (19)
Prev. Close 2.500
Today's Range 2.500 - 2.650
52wk Range 2.340 - 17.17
Shares Outstanding 52,686,426
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Preview: Altimmune's Earnings
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 59 companies set new 52-week lows. 
Via Benzinga

Performance

YTD
-83.37%
-83.37%
1 Month
-1.89%
-1.89%
3 Month
-24.64%
-24.64%
6 Month
-41.18%
-41.18%
1 Year
-79.73%
-79.73%

More News

Read More
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Altimmune: Q1 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Earnings Preview: Altimmune
Via Benzinga
Short Volatility Alert: Altimmune Inc
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
Via Benzinga
Metabolic Syndrome: The Silent Epidemic On The Rise And How BioRestorative Therapies Inc. Is Helping Fight It
Via Benzinga
7 Analysts Have This to Say About Altimmune
Via Benzinga
The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy
Via InvestorPlace
7 Biotech Stocks With Huge Return Potential for Long-Term Investors
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 Cheap Stocks That Are Worth Your Attention
Via InvestorPlace
BioRestorative Therapies (NASDAQ: BRTX) Is Targeting The Global Obesity Epidemic With Its Recent IP Portfolio Expansion
Via Benzinga
Should You Buy Viking Therapeutics Stock After It Skyrocketed Over 60%?
Via The Motley Fool
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Via MarketBeat
Is Viking Therapeutics a Smart Buy on the Dip?
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2023
Via Benzinga
Wall Street Absolutely Loved This Biotech Stock. But It Just Crashed More Than 50%.
Via The Motley Fool
Nasdaq Up Over 100 Points; Crude Oil Rises 2%
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.